Saatja: "Carmen Katariina Sikk" <
[email protected]>
Saaja:
[email protected]
Teema: Vs: Press Question from Euractiv Journalist Re: Benzene in Acne Products
Kuupäev: 2024-04-17 11:12
Hello Olivia
Unfortunately we cannot arrange a (video) call for you with our specialist
for this week, but I will forward you a written answer from our specialist
Laivi Saaremäel (Head of Bureau of Quality Assessment):
Thank you for contacting us and bringing up an important topic with respect
to safety of patients.
Hereby we can inform you that currently we do not see urgent need to start
immediate action with respect to medicinal products containing benzoyl
peroxide as in case of authorised products restrictions in storage
conditions are applied. For OTC product AKNEFUG-OXID MILD 50 MG/G, gel as
well as prescription only Duac Gel and Irexime gels the product must be
stored at refrigerator (2 °C…8 °C) and in case of Epiduo gel the restriction
below +25 °C is obligatory. As potential formation of benzene is usually
observed at elevated temperatures such risks in authorised medicines is
mitigated with restrictions in storage conditions. It can also be
highlighted that during the marketing authorisation procedure the ICH Q3C
requirements are strictly followed and any use of benzene in production of
medicines is not accepted. Even in synthesis of the drug substance any
introduction of benzene has to be avoided, hence we can be assured that
presence of benzene in authorised medicinal products is already minimal and
announcements to recall of products containing benzoyl peroxide is not
foreseen at the moment.
Still we would like to remind that several sanitizers or cosmetic products
that are not considered medicines may contain significant amount of benzoyl
peroxide, but which are not under the responsibility of the State Agency of
Medicines, hence we suggest to contact Health Board.
Carmen Katariina Sikk
Agency of Medicines
Head of Communications
Tel 737 4140
[email protected]
From: Olivia Gyapong <
[email protected]
<mailto:
[email protected]> >
Sent: esmaspäev, 15. aprill 2024 14:57
To: Olivia Gyapong <
[email protected]
<mailto:
[email protected]> >
Subject: Press Question from Euractiv Journalist Re: Benzene in Acne
Products
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
Hello,
My name is Olivia Gyapong, and I am a reporter with Euractiv. The FDA in the
USA is being asked to recall several acne products because they were found
to have elevated levels of the carcinogen benzene. I was wondering if your
national regulatory body has been alerted to similar issues with acne
medications/products sold in the EU, and whether it is planning on
announcing a recall of products containing benzoyl peroxide and/or dangerous
concentrations of benzene.
Would someone from your agency be willing to speak with me about this issue
today or later this week? Thank you! You can reach me at +1 240 483 1932, or
I am happy to set up a video call.
Best,
Olivia Gyapong
--
Olivia GYAPONG
Reporter
Read the news from <https://www.euractiv.com/sections/the-capitals/> The
Capitals |
<https://euractiv.us15.list-manage.com/subscribe?u=ec8c3035cd2e0ab2e3760549e&id=c59e2fd7a9>
<https://www.euractiv.com/newsletters/> Subscribe |
<https://www.euractiv.com/contribute/> Donate
<https://lh5.googleusercontent.com/OH1c-QzUZJf7tGSb8peo7mElymogwmb2ncZUcH4Y_2WpSxjWD3QAiOth0MQ-e0M-EJMO19U1ZFYeZ0eM4_B-ZvrnR-qr-bV5zl4gsI2M5yo9aTYfzIEKOYAramqFMG9-81tIyhfgIkUaBEdTGx95_w>
Brussels Network Office - International Press Centre // 1 Bd Charlemagne //
2nd floor // Brussels
Follow us on : <https://twitter.com/EURACTIV> Twitter |
<https://www.facebook.com/EURACTIV> Facebook |
<https://www.instagram.com/euractiv/> Instagram |
<https://www.linkedin.cn/company/euractiv-com> LinkedIn |
<https://www.youtube.com/euractiv> YouTube |
<https://open.spotify.com/show/2FtqXQXSn8PiVHX6H82Yde?si=9oUtYsVJTbW2Dkf29unnIg&dl_branch=1>
Spotify
Find jobs in our <https://jobs.euractiv.com/company/euractiv-39> JobSite